Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000001936 | SCV000553161 | pathogenic | Hereditary spastic paraplegia 31 | 2022-09-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant results in an extension of the REEP1 protein. Other variant(s) that result in a similarly extended protein product (p.Pro172Hisfs*51) have been determined to be pathogenic (Invitae). This suggests that these extensions are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1859). This variant is also known as c.507delC. This frameshift has been observed in individual(s) with hereditary spastic paraplegia (PMID: 16826527, 30637453). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the REEP1 gene (p.Pro171Hisfs*52). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 31 amino acid(s) of the REEP1 protein and extend the protein by 20 additional amino acid residues. |
Equipe Genetique des Anomalies du Developpement, |
RCV000001936 | SCV000778432 | pathogenic | Hereditary spastic paraplegia 31 | 2017-05-17 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847562 | SCV002104924 | pathogenic | Hereditary spastic paraplegia | 2019-05-17 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000001936 | SCV000022094 | pathogenic | Hereditary spastic paraplegia 31 | 2006-08-01 | no assertion criteria provided | literature only |